87 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
8-K
EX-10.2
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
10-K
2023 FY
EX-10.13
INM
InMed Pharmaceuticals Inc
Annual report
29 Sep 23
11:43am
8-K
EX-10.2
q6p839
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
l3ks5k3 50wou7ehku
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
moxmboy2nb7hwxwyx0
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.2
4v2qitm8k
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.1
kp5helcsw1hqwphwjce
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
5sefuh6yrlwi
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
cupwo
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
wj13om
15 Jul 22
Departure of Directors or Certain Officers
8:28pm
8-K
EX-10.3
uv9s7r 0wmzc8nq64q
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
85vx9csm98g18yv
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
krjg6l
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
0q7ve xrth4nz3ivga
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
8-K
EX-10.1
xluvl9as
22 Mar 22
Entry into a Material Definitive Agreement
6:05am